Sunday, February 08, 2004

Drug offers hope for advanced Alzheimer's disease
Canadian doctors have high hopes that a new drug called memantine will help people with moderate to severe Alzheimer's disease.

Memantine was approved in the U.S. in October 2003 and is now being reviewed by Health Canada.

"For sure, it will greatly improve the treatment of patients in the advanced stages of Alzheimer's and will become standard treatment," says Dr. Serge Gauthier, director of the Alzheimer's Disease Research Unit of the McGill Centre for Studies in Aging in Montreal.

No comments: